Allosteric LFA-1 Inhibitors Modulate Natural Killer Cell Function
Natural killer (NK) cells are believed to play an important role in a variety of disease pathologies, including transplant rejection and autoimmunity. None of the therapeutic modalities currently available are known to potently interfere with NK cell activity. Here we demonstrate for the first time...
Saved in:
Published in | Molecular pharmacology Vol. 75; no. 2; pp. 355 - 362 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Pharmacology and Experimental Therapeutics
01.02.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Natural killer (NK) cells are believed to play an important role in a variety of disease pathologies, including transplant
rejection and autoimmunity. None of the therapeutic modalities currently available are known to potently interfere with NK
cell activity. Here we demonstrate for the first time that low molecular weight inhibitors of the integrin lymphocyte function-associated
antigen-1 (LFA-1) readily block NK cell adhesion, activation, and NK cell-mediated cytolysis in vitro, in contrast to other
immunosuppressive agents. These effects were independent of the type of allosteric mechanism by which LFA-1 inhibition was
achieved. In addition, we describe a simple, nonradioactive whole-blood assay that should be suitable to monitor NK cell activation
in clinical practice. Taken together, our study underlines the importance of LFA-1 in NK cell effector functions and indicates
that allosteric LFA-1 inhibitors may become important tools to further elucidate the therapeutic potential of NK cell modulation
in immunological diseases. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0026-895X 1521-0111 |
DOI: | 10.1124/mol.108.051169 |